• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[晚期帕金森病的治疗]

[Treatment of advanced Parkinson's disease].

作者信息

Momose Y, Murata M, Kanazawa I

机构信息

Department of Neurology, Graduate School of Medicine, University of Tokyo.

出版信息

Nihon Rinsho. 2000 Oct;58(10):2061-5.

PMID:11068447
Abstract

After the advent of levodopa, treatment of Parkinson's disease has changed and the activity of daily life of patients has been remarkably improved; whereas, many patients experience various problems such as wearing-off, dyskinesia, dystonia, neuropsychiatric problems, and dysautonomia. Especially, wearing-off and dyskinesia emerge with the change of absorptional pattern of levodopa and could be solved by regulating the timing and the dose of it. Recently, some new drugs for Parkinson's disease have been available and we physician have a wide choice of them. It is important to make a careful choice of and manipulate of doses of drugs after understanding daily life of each patient enough.

摘要

左旋多巴问世后,帕金森病的治疗发生了变化,患者的日常生活活动有了显著改善;然而,许多患者会出现各种问题,如剂末现象、异动症、肌张力障碍、神经精神问题和自主神经功能障碍。特别是,剂末现象和异动症会随着左旋多巴吸收模式的改变而出现,可以通过调整其服用时间和剂量来解决。最近,一些治疗帕金森病的新药已经上市,我们医生有了广泛的选择。在充分了解每位患者的日常生活情况后,谨慎选择和调整药物剂量非常重要。

相似文献

1
[Treatment of advanced Parkinson's disease].[晚期帕金森病的治疗]
Nihon Rinsho. 2000 Oct;58(10):2061-5.
2
[Drug therapy of patients with early-stage parkinson's disease].[早期帕金森病患者的药物治疗]
Nihon Rinsho. 2000 Oct;58(10):2055-60.
3
Ropinirole therapy for Parkinson's disease.罗匹尼罗治疗帕金森病。
Expert Rev Neurother. 2004 Jul;4(4):581-8. doi: 10.1586/14737175.4.4.581.
4
Role of the pharmacist in the effective management of wearing-off in Parkinson's disease.药剂师在帕金森病剂末现象有效管理中的作用
Ann Pharmacother. 2007 Nov;41(11):1842-9. doi: 10.1345/aph.1K348. Epub 2007 Sep 18.
5
[Management of Parkinson's disease in 2009].[2009年帕金森病的管理]
Rev Med Suisse. 2009 Aug 26;5(214):1650-5.
6
[Problems of long-term levodopa therapy in Parkinson's disease].[帕金森病长期左旋多巴治疗的问题]
Nihon Rinsho. 1997 Jan;55(1):65-71.
7
The treatment of early Parkinson's disease: levodopa rehabilitated.早期帕金森病的治疗:左旋多巴重获新生。
Pract Neurol. 2011 Jun;11(3):145-52. doi: 10.1136/practneurol-2011-000011.
8
Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.在晚期帕金森病中,在已有左旋多巴治疗基础上加用多巴胺激动剂与单纯左旋多巴治疗的比较:一项荟萃分析。
Int J Clin Pract. 2009 Apr;63(4):613-23. doi: 10.1111/j.1742-1241.2009.02027.x. Epub 2009 Feb 16.
9
[New therapeutic strategy for Parkinson's disease based on pharmacological profiles].基于药理学特征的帕金森病新治疗策略
Nihon Rinsho. 1997 Jan;55(1):43-51.
10
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.晚期帕金森病中十二指肠左旋多巴输注单一疗法与口服多种药物联合治疗的比较
Neurology. 2005 Jan 25;64(2):216-23. doi: 10.1212/01.WNL.0000149637.70961.4C.